InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,064.20
(
0.91%
)
US TECH 100
17,180.40
(
1.90%
)
Dow Jones
38,225.66
(
0.85%
)
Brent Oil
83.63
(
0.11%
)
Bitcoin
59,290.15
(
1.81%
)

Replies to post #220518 on Biotech Values

Replies to #220518 on Biotech Values

DewDiligence

08/16/18 4:50 PM

#220519 RE: ciotera #220518

Thanks! (eom)

DewDiligence

08/11/21 6:58 PM

#239164 RE: ciotera #220518

FDA approves Keytruda/Lenvima in first-line-RCC:

https://finance.yahoo.com/news/fda-approves-keytruda-pembrolizumab-plus-223000036.html

RCC is the second indication for this combination regimen; it was FDA-approved in first-line HCC in 2018.